Cost-Consequences of Cladribine Tablets for the Treatment of Highly Active Relapsing–Remitting Multiple Sclerosis in Italy.
Saved in:
| Title: | Cost-Consequences of Cladribine Tablets for the Treatment of Highly Active Relapsing–Remitting Multiple Sclerosis in Italy. |
|---|---|
| Authors: | Polistena, Barbara1 (AUTHOR) barbara.polistena@uniroma2.it, Provenzano, Anna Maria2 (AUTHOR), Rizzi, Caterina2 (AUTHOR), Colombo, Elena3 (AUTHOR), Bergamaschi, Roberto3 (AUTHOR) |
| Source: | Neurology & Therapy. Aug2025, Vol. 14 Issue 4, p1507-1520. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21938253 |
|---|---|
| DOI: | 10.1007/s40120-025-00761-7 |
